PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 10, 2025Rheumatology Advances in Practice1 citationsOpen Access

Early diagnosis of axial spondyloarthritis among patients with chronic back pain using a clinical screening tool and referral strategy

View Full Paper
ADAbhijeet DanveSASwetha Ann AlexanderYAYuliya Afinogenova

Key Points

  • A self-referral strategy increased the early diagnosis of axial spondyloarthritis in chronic back pain patients.
  • Of the enrolled patients, 34% received a diagnosis of axSpA, indicating a significant detection rate.
  • The A-tool showed varying sensitivity and specificity for diagnosing axSpA, highlighting room for improvement.
  • The study indicates a need for larger trials to validate the effectiveness of the A-tool in real-world settings.

Abstract

Abstract Objective Lack of timely referral of suspected axSpA patients to rheumatologists is an important modifiable reason for diagnostic delay of axial spondyloarthritis (axSpA). We assessed the usefulness of a self-referral strategy using a clinical feature-based screening questionnaire (A-tool). Methods Finding axSpA (FaxSpA) was single-center prospective study involving patients with chronic back pain (CBP). The A-tool, consisting of a three-question prescreen and eight-question screening questionnaire (SQ), was distributed to patients via the patient communication portal and university Facebook page. Patients with affirmative responses on all three prescreen questions, and three or more questions on SQ were eligible for study visit. Enrolled patients underwent history, physical examination, labs (CRP and HLA-B27), and imaging studies (X-ray and MRI of the pelvis). The clinician’s judgment was considered the gold standard for diagnosing axSpA. Results Eighty-six of the 100 enrolled patients completed all the study procedures, and 29 (34%) were diagnosed with axSpA. Seven patients had ankylosing spondylitis, and 22 had non-radiographic axSpA. Sensitivity and specificity of the individual A-tool questions for diagnosing axSpA ranged from 0.03–0.86 and 0.14–0.96, respectively. Positive likelihood ratios (+LR) of the individual items in the A-tool ranged from 0.84 to 1.34. There was low to moderate agreement between the patient responses on the online A-tool and the corresponding physician-confirmed responses. Conclusion A tool-based strategy for self-referral of CBP patients is a simple, practical, and feasible approach for early diagnosis of axSpA. We need a larger prospective study to validate our findings.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Danve et al. (2025) studied this question.

synapsesocial.com/papers/68c1ae7054b1d3bfb60e657bhttps://doi.org/10.1093/rap/rkaf086
Ask AI
Helpful
Bookmark
Share
View Full Paper